HYFT

MindWalk Holdings Corp.

$1.57 -0.05 (-3.09%) At close · Jul 2

Market Cap

$76.14M

46,154,118

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date	Headline
2026-07-06	MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity
2026-07-01	MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery
2026-06-12	MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
2026-06-10	MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery
2026-06-02	MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns
2026-05-27	MindWalk Holdings Deploys Pandemic Response Platform via HYFT® Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coverage
2026-05-18	The Biology Came First.
2026-03-12	MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results
2026-03-06	MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era
2026-03-02	MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026
2026-01-27	MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics
2026-01-14	MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease

Past events

Date	Event	Type
2026-03-12	MindWalk Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2026 on March 12, 2026	Event
2025-12-15	MindWalk Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025	Event
2025-09-15	MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025	Event
2025-07-29	IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025	Event
2025-06-03	ImmunoPrecise Antibodies (IPA) to Present at Maxim Group’s 2025 Virtual Tech Conference	Conference
2025-03-28	ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025	Event
2025-03-19	Experience Bio-Native AI at NVIDIA GTC 2025: BioStrand & Vultr Unveil LENSᵃⁱ™ Powered by HYFT	Event
2025-03-17	NVIDIA GTC 2025, the conference for the era of AI	Conference
2025-01-21	Sequire Investor Summit	Event
2025-01-13	Join IPA at the prestigious JPM 2025!	Event
2024-12-13	AIDD 2024 Fireside Chat	Event
2024-12-11	IPA to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference	Conference
2024-12-10	IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 on December 10, 2024	Event
2024-11-13	AI Driven Drug Discovery Summit USA	Event
2024-09-16	IPA reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025	Event
2024-09-09	ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York	Conference
2024-07-29	IPA Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2024	Event
2024-03-14	IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024	Event
2023-12-14	IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024	Event
2023-11-09	IMMUNOPRECISE ANTIBODIES LTD. Annual General Meeting of Shareholders 2023	Shareholder meeting
2023-09-14	IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024	Event
2023-07-23	Radius Research - Immunoprecise Antibodies (IPA) CEO Jennifer Bath outlines it's AI initiatives in Driving Growth	Event
2023-07-07	IPA Reports Financial Results and Recent Business Highlights for Fourth Quarter Fiscal Year 2023	Event
2023-06-15	Jefferies Healthcare Conference 2023	Conference
2023-03-16	IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023	Event

Source: https://ir.mindwalkai.com/overview/default.aspx

Key facts CIK 1715925 CUSIP 602687105 Visit website Investor relations